Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SC 13G

SEC Filing Details

Document Details

Filing Date
Feb 1, 2018
Document Date
Feb 1, 2018
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved